El Sobrante, CA, United States of America

Gary A Van Nest

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 91(Granted Patents)


Company Filing History:


Years Active: 1989-1998

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Gary A Van Nest: Innovator in Vaccine Development

Introduction

Gary A Van Nest is a notable inventor based in El Sobrante, California. He has made significant contributions to the field of vaccine development, holding 2 patents that focus on innovative vaccine compositions and methods for producing immunologically reactive polypeptides.

Latest Patents

One of his latest patents is for vaccine compositions containing liposomes. This patent describes a vaccine composition that includes an antigenic substance in association with a liposome and an oil-in-water emulsion comprising a muramyl peptide, a metabolizable oil, and optionally an additional emulsifying agent. The combination of these components is designed to produce high levels of immune response. Another significant patent involves feline leukemia virus protein vaccines. This patent provides methods and compositions for the efficient production of a polypeptide that has immunological reactivity corresponding to naturally-occurring envelope glycoproteins of the feline leukemia virus. It includes a DNA construct recognized by yeast, which enhances the yields of the product when transformed into a yeast host.

Career Highlights

Gary A Van Nest has worked with Chiron Corporation, where he has been able to apply his expertise in vaccine technology. His work has contributed to advancements in immunology and vaccine efficacy.

Collaborations

Throughout his career, he has collaborated with notable colleagues such as Gail L Barchfeld and Gary S Ott, further enhancing the impact of his work in the field.

Conclusion

Gary A Van Nest is a distinguished inventor whose work in vaccine development has led to important advancements in immunology. His innovative patents reflect his commitment to improving vaccine efficacy and public health.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…